Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Synthesis and in vitro biological evaluation of 1,3-bis-(1,2,3-triazol-1-yl)-propan-2-ol derivatives as antifungal compounds fluconazole analogues

Journal Article · · Medicinal Chemistry Research (Print)
; ;  [1];  [2];  [3]; ;  [4]; ; ;  [1]
  1. Centro Conjunto de Investigación en Química Sustentable UAEM-UNAM. Universidad Autónoma del Estado de México (Mexico)
  2. Universidad Autónoma del Estado de Mexico, Facultad de Medicina (Mexico)
  3. Signa S.A. de C.V., Av. Industria Automotriz No. 301, Zona Industrial Toluca (Mexico)
  4. Universidad Autónoma del Estado de Mexico, Departamento de Microbiología, Facultad de Química (Mexico)

A novel series of 1,3-bis-(1,2,3-triazol-1-yl)-propan-2-ol derivatives was synthesized from 1-aryl-1,3-diazidopropan-2-ol derivatives and diverse alkynes using copper catalyzed azide-alkyne cycloaddition in the key step. Most of synthesized compounds showed high activity against Candida spp. strains at a 0.04–0.5 μg/mL concentration range compared to Itraconazole and Fluconazole (MIC 2.56 and 1.28 μg/mL, respectively), which were used as reference compounds. A 1,3-bis-(1,2,3-triazol-1-yl)-propan-2-ol derivative (R{sup 1} = F and R{sup 2} = cyclopropyl) displayed an outstanding selectivity against Candida albicans and Candida krusei (MIC = 0.0075 µg/mL). Moreover, Artemia salina bioassay on 1,3-bis-(1,2,3-triazol-1-yl)-propan-2-ol derivatives revealed low toxicity in this kind of compounds. In addition, molecular docking studies suggest good binding affinity of halogen atoms in some 1-aryl-1,3-diazidopropan-2-ol derivatives to HEME group present in 14-alpha demethylase (CYP51), which might explain the high antifungal activity found in these compounds.

OSTI ID:
22936201
Journal Information:
Medicinal Chemistry Research (Print), Journal Name: Medicinal Chemistry Research (Print) Journal Issue: 4 Vol. 28; ISSN 1054-2523
Country of Publication:
United States
Language:
English

Similar Records

Design, synthesis and molecular docking studies of quinazolin-4-ones linked to 1,2,3-triazol hybrids as Mycobacterium tuberculosis H{sub 37}Rv inhibitors besides antimicrobial activity
Journal Article · Mon Apr 15 00:00:00 EDT 2019 · Medicinal Chemistry Research (Print) · OSTI ID:22936202

Fluconazole Binding and Sterol Demethylation in Three CYP51 Isoforms Indicate Differences in Active Site Topology
Journal Article · Mon Nov 15 23:00:00 EST 2010 · J. Lipid Res. · OSTI ID:1008752

Fluconazole is a potent inhibitor of antipyrine metabolism in vivo in mice
Journal Article · Sat Dec 31 23:00:00 EST 1988 · Drug Metab. Dispos.; (United States) · OSTI ID:5767947